Home / Cardiovascular system / Olmesartan Medoxomil
ATC C09CA08 · Agents Acting On The Renin-Angiotensin System
Olmesartan Medoxomil shortage
As of 31 Oct 2026, Olmesartan Medoxomil has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 18 products.
Countries3/5
Products18packs or presentations
Short since30 Jul 20224.3 years ago
Earliest return26 Dec 2026company estimate
No return date12products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | OLMESARTAN MEDOXOMIL ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Jul 2022 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Jul 2022 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | OLMESARTAN MEDOXOMIL ACCORD | ACCORD HEALTHCARE, S.L.U. | 30 Oct 2025 | not given | Increased demand Elevata richiesta |
| IT | OLMESARTAN MEDOXOMIL ACCORD | ACCORD HEALTHCARE, S.L.U. | 25 Dec 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL ACCORD | ACCORD HEALTHCARE, S.L.U. | 24 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | OLMESARTAN MEDOXOMIL MYLAN | MYLAN S.P.A. | 1 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL SANDOZ | SANDOZ S.P.A. | 14 Sep 2026 | not given | Increased demand Elevata richiesta (carenza relativa solo al canale retail) |
| IT | OLMESARTAN MEDOXOMIL PENSA announced | TOWA PHARMACEUTICAL S.P.A. | 1 Nov 2026 | 30 Jun 2027 | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL ZENTIVA announced | ZENTIVA ITALIA S.R.L. | 30 Nov 2026 | not given | Increased demand Elevata richiesta |
| IT | OLMETEC announced | DAIICHI SANKYO ITALIA S.P.A. | 30 Nov 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMETEC announced | DAIICHI SANKYO ITALIA S.P.A. | 30 Nov 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMETEC announced | DAIICHI SANKYO ITALIA S.P.A. | 30 Nov 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMESARTAN MEDOXOMIL AUROBINDO announced | AUROBINDO PHARMA (ITALIA) S.R.L. | 9 Dec 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| ES | ATOLME 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | Laboratorios Alter S.A. | 15 Oct 2026 | 30 Dec 2026 | Not stated |
| ES | OLMETEC 10 mg COMPRIMIDOS RECUBIERTOS , 28 comprimidos | Daiichi Sankyo Espana S.A. | 26 Oct 2026 | 26 Dec 2026 | Not stated |
| BE | Olmetec 20 mg film-coat. tabl. 28 | Daiichi Sankyo Belgium | 29 May 2026 | 4 Jan 2027 | Manufacturing problem Delay in production |
| BE | Olmesartan Krka 10 mg film-coat. tabl. 98 | KRKA d.d. Novo mesto | 7 Oct 2026 | 1 Jan 2027 | Other Other reason |
| BE | Olmetec 20 mg film-coat. tabl. 98 announced | Daiichi Sankyo Belgium | 5 Nov 2026 | 4 Jan 2027 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.